Oxford Nanopore, the Oxford University company developing handheld DNA sequencers, has secured £109.5m ($144.4m) in its latest financing round.
The round was comprised of £29.3m in new capital and a further £80.2m from the sale of shares. Backers include a range of new and existing investors from Europe, the US and Asia.
The company did not disclose what it intends to do with its latest raise. To date, Nanopore has secured around £480m and has a valuation around £1.5bn.